Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Benoîte Mery1, Antoine Thiery-Vuillemin2, Christophe Massard3

  • 1Département d'oncologie médicale, institut de cancérologie Lucien-Neuwirth 108 bis, avenue Albert-Raimond, BP 60008, 42270 Saint-Priest-en-Jarez, cedex, France.

Bulletin Du Cancer
|January 1, 2019
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

BRCA pathogenic variants and response in early TNBC patients treated with neoadjuvant pembrolizumab: outcomes of the BRCAPATH study.

Breast cancer (Tokyo, Japan)·2026
Same author

Adenoid cystic carcinoma of the breast: a case series of 26 patients.

Breast cancer research and treatment·2026
Same author

ATTITUDE - Addressing attrition in longitudinal cancer cohorts: an in-depth qualitative analysis of experiences and perspectives on participation in longitudinal studies among breast cancer survivors.

Breast cancer research and treatment·2026
Same author

Soluble MAdCAM-1 as a biomarker in metastatic renal cell carcinoma.

Nature medicine·2026
Same author

Targeting the JAK/STAT Signaling Pathway in Breast Cancer: Leaps and Hurdles.

Biomedicines·2025
Same author

Nivolumab in Metastatic Clear-cell Renal Cell Carcinoma: An Integrative Biomarker Analysis from the NIVOREN GETUG-AFU 26 Phase 2 Study.

European urology·2025

New trends in renal cell cancer (RCC) are emerging, offering novel perspectives for treatment and patient outcomes. This research highlights key advancements in understanding and managing this complex disease.

Area of Science:

  • Oncology
  • Nephrology
  • Cancer Research

Background:

  • Renal cell carcinoma (RCC) remains a significant global health challenge.
  • Understanding the evolving landscape of RCC is crucial for improving patient care.
  • Recent scientific breakthroughs are reshaping the therapeutic strategies for RCC.

Discussion:

  • The abstract discusses novel therapeutic targets and treatment modalities for renal cell carcinoma.
  • It explores the integration of precision medicine and immunotherapy in RCC management.
  • Emerging diagnostic tools and prognostic markers are also considered.

Key Insights:

  • Significant progress has been made in targeted therapies and immunotherapies for advanced RCC.
  • Early detection and risk stratification methods are continuously improving.

Related Experiment Videos

  • The multidisciplinary approach is vital for optimizing treatment outcomes in RCC.

    • Outlook:

    • Future research will likely focus on overcoming treatment resistance and enhancing long-term survival.
    • Personalized treatment algorithms based on molecular profiling are anticipated.
    • Continued exploration of novel drug combinations and treatment sequencing is expected.